CCR2 and exocrine pancreatic carcinoma: In contrast, CCR2 inhibition attenuates the mobilization and thus leads to forming an anti-tumoral immune environment in KCKO pancreatic carcinoma and MC38 colorectal carcinoma (45, 46).